- Home
- NBIX vs DT Comparison
NBIX vs DT Comparison
Compare NBIX & DT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- DT
- Stock Information
- Founded
- NBIX 1992
- DT 2005
- Country
- NBIX United States
- DT United States
- Employees
- NBIX 1448
- DT N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- DT Computer Software: Prepackaged Software
- Sector
- NBIX Health Care
- DT Technology
- Exchange
- NBIX Nasdaq
- DT Nasdaq
- Market Cap
- NBIX 11.8B
- DT 13.2B
- IPO Year
- NBIX 1996
- DT 2019
- Fundamental
- Price
- NBIX $117.44
- DT $52.35
- Analyst Decision
- NBIX Buy
- DT Buy
- Analyst Count
- NBIX 24
- DT 25
- Target Price
- NBIX $163.91
- DT $60.50
- AVG Volume (30 Days)
- NBIX 1.0M
- DT 2.9M
- Earning Date
- NBIX 10-30-2024
- DT 11-07-2024
- Dividend Yield
- NBIX N/A
- DT N/A
- EPS Growth
- NBIX 97.40
- DT N/A
- EPS
- NBIX 3.73
- DT 0.54
- Revenue
- NBIX $2,242,800,000.00
- DT $1,563,293,000.00
- Revenue This Year
- NBIX $26.97
- DT $20.03
- Revenue Next Year
- NBIX $16.69
- DT $15.61
- P/E Ratio
- NBIX $31.50
- DT $96.97
- Revenue Growth
- NBIX 25.72
- DT 20.58
- 52 Week Low
- NBIX $108.14
- DT $39.42
- 52 Week High
- NBIX $157.98
- DT $61.41
- Technical
- Relative Strength Index (RSI)
- NBIX 42.69
- DT 42.36
- Support Level
- NBIX $119.08
- DT $53.02
- Resistance Level
- NBIX $129.67
- DT $54.42
- Average True Range (ATR)
- NBIX 3.34
- DT 1.57
- MACD
- NBIX -0.02
- DT -0.28
- Stochastic Oscillator
- NBIX 14.59
- DT 6.23
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
About DT Dynatrace Inc.
Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.